Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Na ïve and Dengue-Immune Adults

Condition:   Dengue Fever Intervention:   Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV) Sponsor:   Takeda Not yet recruiting

Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials